Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection.

Hong, Y A

Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection. [electronic resource] - Transplantation proceedings Jan 2012 - 182-4 p. digital

Publication Type: Journal Article

1873-2623

10.1016/j.transproceed.2011.12.006 doi


Adult
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Biopsy
Chronic Disease
Drug Therapy, Combination
Female
Graft Rejection--diagnosis
HLA Antigens--immunology
Humans
Immunity, Humoral--drug effects
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Isoantibodies--blood
Kidney Transplantation--immunology
Male
Proteinuria--drug therapy
Republic of Korea
Rituximab
Time Factors
Treatment Outcome